Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.

NCT04640324 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Insulin Resistance

Interventions

DRUG: Nutraceutical therapy

Sponsor

University of Campania Luigi Vanvitelli

Collaborators

[object Object]
[object Object]